Yoshida, Hideo
Publications
ShowIwata H, Goettsch C, Sharma A, Ricchiuto P, Goh WW, Halu A, Yamada I, Yoshida H, Hara T, Wei M, Inoue N, Fukuda D, Mojcher A, Mattson PC, Barabási AL, Boothby M, Aikawa E, Singh SA, Aikawa M
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.
Yoshida H, Ashikawa Y, Itoh S, Nakagawa T, Asanuma A, Tanabe S, Inoue Y, Hidaka H
K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model.
PLOS One. 2012;7(10):e46432 - PMID: 23110051 - PMCID: PMC3479105 - DOI: 10.1371/journal.pone.0046432
Yoshida H, Ashikawa Y, Itoh S, Nakagawa T, Asanuma A, Tanabe S, Inoue Y, Hidaka H
K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model.
PLOS One. 2012;7(10):e46432 - PMID: 23110051 - PMCID: PMC3479105 - DOI: 10.1371/journal.pone.0046432
Sasaki Y, Suzuki H, Itoh S, Yoshida H, Kondo S, Inoue K, Tanabe S
K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models.
Eur J Pharmacol. 2012;689(1-3):132-8 - PMID: 22659587 - DOI: 10.1016/j.ejphar.2012.05.014
Sasaki Y, Suzuki H, Itoh S, Yoshida H, Kondo S, Inoue K, Tanabe S
K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models.
Eur J Pharmacol. 2012;689(1-3):132-8 - PMID: 22659587 - DOI: 10.1016/j.ejphar.2012.05.014
Yoshida H, Itoh S, Hara T, Sasaki Y, Kondo S, Nakagawa T, Asanuma A, Tanabe S
A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease.
Atherosclerosis. 2012;221(1):84-90 - PMID: 22269153 - DOI: 10.1016/j.atherosclerosis.2011.12.044
Yoshida H, Itoh S, Hara T, Sasaki Y, Kondo S, Nakagawa T, Asanuma A, Tanabe S
A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease.
Atherosclerosis. 2012;221(1):84-90 - PMID: 22269153 - DOI: 10.1016/j.atherosclerosis.2011.12.044
Yoshida H, Okamura Y, Watanabe N, Ikeda Y, Handa M
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation.
Thromb Haemost. 2010;105(3):487-95 - PMID: 21136009 - DOI: 10.1160/TH10-07-0439
Nagaoka K, Takahara K, Tanaka K, Yoshida H, Steinman RM, Saitoh S, Akashi-Takamura S, Miyake K, Kang YS, Park CG, Inaba K
Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria.
Takahara K, Yashima Y, Omatsu Y, Yoshida H, Kimura Y, Kang YS, Steinman RM, Park CG, Inaba K
Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins.
Int Immunol. 2004;16(6):819-29 - PMID: 15096474 - DOI: 10.1093/intimm/dxh084